Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia

International Psychogeriatrics

Volumn 22, Issue 7, 2010, Pages 1149-1153

  O'Connor, Daniel W ^a   Griffith, Joanne ^a   McSweeney, Kate ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

antidepressant; Antipsychotic; benzodiazepine; nursing homes; prescribing

Indexed keywords

BENZODIAZEPINE DERIVATIVE; PSYCHOTROPIC AGENT;

AGED; ARTICLE; AUSTRALIA; CLINICAL PRACTICE; DRUG USE; FEMALE; HOME FOR THE AGED; HOSPITAL PATIENT; HUMAN; MALE; MEDICAL RECORD; MENTAL DISEASE; MIDDLE AGED; NURSING HOME; PRESCRIPTION; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE; STATISTICS; TIME;

AGED; AGED, 80 AND OVER; AUSTRALIA; BENZODIAZEPINES; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HOMES FOR THE AGED; HUMANS; INPATIENTS; MALE; MEDICAL RECORDS; MENTAL DISORDERS; MIDDLE AGED; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; SEX FACTORS; TIME FACTORS;

EID: 79952118915     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610210000165     Document Type: Article

References (34)

1. American Geriatrics Society and American Association for Geriatric Psychiatry (2003). Consensus statement on improving the quality of mental health care in U.S. nursing homes: management of depression and behavioural symptoms associated with dementia. Journal of the American Geriatrics Society, 51, 1287-1298.
2. Ballard, C. G. et al. (2004). A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. Journal of Clinical Psychiatry, 65, 114-119.
3. Banerjee, S., Shamash, K., Macdonald, A. J. D., Mann, A. H. (1996). Randomised controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home. BMJ, 1996, 1058-1061.
4. Blanchard, M. R., Waterreus, A. and Mann, A. H. (1995). The effect of a primary care nurse intervention upon older people screened as depressed. International Journal of Geriatric Psychiatry, 10, 289-298.
5. Brodaty, H. et al. (2001). Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors. International Journal of Geriatric Psychiatry, 16, 504-512.
6. Bronskill, S. E. et al. (2004). Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose and specialist contact. Journal of the American Geriatrics Society, 52, 749-755.
7. Bruce, M. L. et al. (2004). Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA, 291, 1081-1091.
8. Carlson, W. L. and Snowden, M. (2007). Improving treatment for depression in the nursing home population: integrating the model of the depression care manager. Harvard Review of Psychiatry, 15, 128-132.
9. Chow, E. S. L. et al. (2004). The prevalence of depressive symptoms among elderly Chinese private nursing home residents in Hong Kong. International Journal of Geriatric Psychiatry, 19, 734-740.
10. Cohen-Mansfield, J. et al. (1999). Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Archives of Internal Medicine 159, 1733-1740.
11. Conn, D. K., Ferguson, I., Mandelman, K. and Ward, C. (1999). Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada. International Psychogeriatrics, 11, 223-233.
12. Draper, B. et al. (2001). Use of psychotropics in Sydney nursing homes: associations with depression, psychosis and behavioral disturbances. International Psychogeriatrics, 13, 107-120.
13. Gobert, M. and D'hoore, W. (2005). Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. International Journal of Geriatric Psychiatry, 20, 712-721.
14. Greve, M. and O'Connor, D. (2005). A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia. International Psychogeriatrics, 17, 165-178.
15. Hosia-Randell, H. and Pitk̈al̈a, K. (2005). Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs and Aging, 22, 793-800.
16. International Psychogeriatric Association (2003). Behavioral and Psychological Symptoms of Dementia. Chicago, IL: IPA.
17. Llewellyn-Jones, R. H., Baikie, K. A., Smithers, H., Cohen, J. and Snowdon, J. (1999). Multi-faceted shared care intervention for late life depression in residential care: randomized controlled trial. BMJ, 1999, 676-682.
18. Lövheim, H, Sandman, P. O., Kallin, K., Karlsson, S. and Gustafson, Y. (2008). Symptoms of mental health and psychotropic drug use in geriatric care, changes between 1982 and 2000. International Journal of Geriatric Psychiatry, 23, 289-294.
19. Mann, E., Köpke, S., Haastert, B., Pitkäla, K. and Meyer, G. (2009). Psychotropic medication use among nursing home residents in Austria: a cross-national study. BMC Geriatrics. doi: 10.1186/1471-2318-9-18.
20. McSweeney, K. and O'Connor, D. W. (2008). Depression among newly admitted Australian nursing home residents. International Psychogeriatrics, 20, 724-737.
21. Mulsant, B. H. et al. (2001). Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm. International Journal of Geriatric Psychiatry, 16, 585-592.
22. Nakajima, G. A. and Wenger, N. S. (2007). Quality indicators for the care of depression in vulnerable elders. Journal of the American Geriatrics Society, 55, S302-S311.
23. Nijk, R. M., Zuidema, S. U. and Koopmans, R. T. C. M. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. International Psychogeriatrics, 21, 485-493.
24. Roberts, M. S. et al. (2001). Outcomes of an RCT of a clinical pharmacy intervention in 52 nursing homes. British Journal of Clinical Pharmacology, 51, 257-65.
25. Ryan, J. M., Kidder, S. W., Daiello, L. A. and Tariot, P. N. (2002). Psychopharmacologic interventions in nursing homes: what do we know and where should we go? Psychiatric Services, 53, 1407-1413.
26. Schmidt, I. et al. (1998). The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. Journal of the American Geriatrics Society, 46, 77-82.
27. Selbæk, G., Kirkevold, Ø. and Engedal, K. (2008). The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes -a 12-month follow-up study. American Journal of Geriatric Psychiatry, 16, 528-536.
28. Shrank, W. H., Polinski, J. M. and Avorn, J. (2007). Quality indicators for medication use in vulnerable elders. Journal of the American Geriatrics Society, 55, S373-S382.
29. Smalbrugge, M., Jongenelis, L., Pot, A. M., Eefsting, J. A., Ribbe, M. W. and Beekman, A. T. F. (2006). Incidence and outcome of depressive symptoms in nursing home residents in the Netherlands. American Journal of Geriatric Psychiatry, 14, 1069-1076.
30. Snowden, M., Sato, K. and Roy-Byrne, P. (2003). Assessment and treatment of nursing home residents with depression and behavioral symptoms associated with dementia: a review of the literature. Journal of the American Geriatrics Society, 51, 1305-1317.
31. Snowdon, J., Vaughan, R., Miller, R., Burgess, E. E. and Tremlett, P. (1995). Psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 163, 70-72.
32. Snowdon, J., Day, S. and Baker, W. (2006). Current use of psychotropic medication in nursing homes. International Psychogeriatrics, 18, 241-250.
33. Sørensen, L., Foldspang, A., Gulmann, N. C. and Munk-Jørgensen, P. (2001). Determinants for the use of psychotropics among nursing home residents. International Journal of Geriatric Psychiatry, 16, 147-154.
34. Unützer, J. et al. (2002). Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA, 288, 2836-2845.